Doris BraunDoris Braun, Mag. pharm. Dr.
Research associate

Phone: +43 512 507 58651
Mail: doris.braun@uibk.ac.at

University of Innsbruck, Institute of Pharmacy, Pharmaceutical Technology
Josef-Moeller-Haus, Innrain 52c, A-6020 Innsbruck, Austria

                  
Biography

                  
Publications

                  
Research

                  
Teaching

Biographic data

Doris E. Braun, Mag. pharm. Dr.
born 27.10.1980 in Hohenems, Austria

Related Activities and Further Trainings

since 03 2005

Assistant teacher at the Institute of Pharmacy/University of Innsbruck, Austria

07 2012

Research stay at Eli Lilly & Company (Dr. Susan Reutzel-Edens)

02 2010, 07 2011
and 04 2012

Research stay at Strathclyde Institute of Pharmacy and Biomedical Sciences/
University of Strathclyde (Prof. Alastair J. Florence)

06 2007

Summerschool on Engineering of Crystalline Materials Properties 39th crystallographic meeting at Erice, Sicily

05 2005

Course in Multivariate Data Analysis and Modelling, Umetrics Academy, Frankfurt, Germany

09 2001, 02 2002
and 07 2002

Pharmacy (Internship) Apotheke im Messepark, Dornbirn

Education

04 2011 – 06 2012

Research Associate at the Chemistry Department/University College London

04 2009 – 03 2011

Honorary Research Assistant at the Chemistry Department/University College London
Erwin Schrödinger Abroad Fellowship (Austrian Science Fund)

08 2008 – 01 2009

Post-Doctoral researcher at the Institute of Pharmacy/University of Innsbruck
Forschungsstipendium an österreichische Graduierte (Fellowship from the University of Innsbruck)

09 2004 – 09 2008

PhD in Natural Sciences Institute of Pharmacy/University of Innsbruck
Supervisor: Prof. Dr. Ulrich J. Griesser

Thesis Title: "Crystal polymorphism and structure property relationships of drug compounds: statistical aspects, analytical strategies and case studies"

10 1999 – 06 2004

Diploma in Pharmacy (Mag. pharm.) Institute of Pharmacy/University of Innsbruck
Supervisor: Prof. Dr. Ulrich J. Griesser

Diploma Thesis Title: "Statistische Analyse von Festkörpereigenschaften organischer Arzneistoffe der Pharmacopoea Europaea 4 – unter besonderer Berücksichtigung von Polymorphie und Pseudopolymorphie"

06 1999

A-levels